Beyond Air (XAIR) Cash from Investing Activities (2016 - 2026)
Beyond Air (XAIR) reported Cash from Investing Activities of -$447000.0 for Q1 2026, down 117.32% on a YoY basis from $2.6 million in Q1 2025, and up 88.94% sequentially from -$4.0 million in Q4 2025.
Beyond Air (XAIR) Cash from Investing Activities (2016 - 2026) Analysis & Trends
Beyond Air (XAIR) has 11 years of Cash from Investing Activities data on file, last reported at -$447000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Investing Activities fell 117.32% year-over-year to -$447000.0; the trailing twelve-month figure through Mar 2026 stood at -$3.4 million (down 144.71% YoY), and the FY2026 full-year result was -$3.7 million, down 124.65% from the prior year.
- Cash from Investing Activities grew to -$447000.0 in Q1 2026, from -$4.0 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $8.9 million in Q3 2024 to a low of -$33.6 million in Q3 2022.
- A 5-year average of -$1.7 million and a median of -$264000.0 in 2022 frame the typical range for Cash from Investing Activities.
- Across the five-year window, Cash from Investing Activities slumped 4948.27% in 2022 and soared 2713.57% in 2023, its largest moves.
- Tracing XAIR's Cash from Investing Activities over 5 years: stood at $4.4 million in 2022, then sank by 80.56% to $853000.0 in 2023, then slumped by 913.25% to -$6.9 million in 2024, then jumped by 41.72% to -$4.0 million in 2025, then jumped by 88.94% to -$447000.0 in 2026.
- Business Quant data shows XAIR's Cash from Investing Activities at -$447000.0 in Q1 2026, -$4.0 million in Q4 2025, and $486000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | -298.50 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -2.50 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | -475.32 Mn |
| 10 | Beyond Air | 2.23 Mn | -10.13 Mn | 94,000.00 | -447,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -447,000.00 |
| Mar 31, 2026 | -447,000.00 |
| Dec 31, 2025 | -4.04 Mn |
| Dec 31, 2025 | -4.04 Mn |
| Sep 30, 2025 | 486,000.00 |
| Sep 30, 2025 | 486,000.00 |
| Jun 30, 2025 | 576,000.00 |
| Jun 30, 2025 | 576,000.00 |
| Mar 31, 2025 | 2.58 Mn |
| Mar 31, 2025 | 2.58 Mn |
| Dec 31, 2024 | -6.94 Mn |
| Dec 31, 2024 | -6.94 Mn |
| Sep 30, 2024 | 8.91 Mn |
| Sep 30, 2024 | 8.91 Mn |
| Jun 30, 2024 | 3.11 Mn |
| Jun 30, 2024 | 3.11 Mn |
| Mar 31, 2024 | -1.67 Mn |
| Mar 31, 2024 | -1.67 Mn |
| Dec 31, 2023 | 853,000.00 |
| Dec 31, 2023 | 853,000.00 |